Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Lartruvo (olaratumab) for the Treatment of Soft Tissue Sarcoma

Drug (Brand / Generic)

Lartruvo (olaratumab)

Product Description

Monoclonal antibody

Current Indication

Soft tissue sarcoma

Market Sector

Oncology

Developer

Eli Lilly

Development Status

Approved in the US and Europe
Expand

Go Top